Dr. Robert Rintoul

Biography

Robert Rintoul is a Professor of Thoracic Oncology at the University of Cambridge and an Honorary Consultant Respiratory Physician at the Royal Papworth Hospital. He graduated in medicine from the University of Edinburgh and undertook pre-clinical training at the University of St Andrews. Rintoul later trained in respiratory medicine in London and Edinburgh, earning his doctorate from the University of Edinburgh for his research on mechanisms of chemotherapy resistance in small cell lung cancer. He became a consultant in respiratory medicine specializing in thoracic oncology at Royal Papworth Hospital in 2005 and moved to the University of Cambridge in 2017. He co-leads the Thoracic Cancer Programme at the Cancer Research UK Cambridge Cancer Centre and serves as the Director of the Papworth Trials Unit. In 2021, he was appointed as the clinical lead of the Clinical Advisory Group for the UK Lung Cancer Coalition and is currently the clinical director of the Cambridgeshire and Peterborough lung cancer screening programme. His research focuses on early-stage lung cancer and pleural mesothelioma, emphasizing translational clinical trials and biomarker discovery for early detection. He founded Mesobank UK, a national bioresource for malignant mesothelioma, which supports research by providing access to mesothelioma tissue.

Research Interests